Viewing Study NCT01466335


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-25 @ 8:06 PM
Study NCT ID: NCT01466335
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2011-10-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module